Displaying 481 - 490 of 631
Obesity is a key driver of insulin resistance and the development of type 2 diabetes, and it is also linked to an increased risk of certain cancers. Managing diabetes and obesity in patients with cancer presents unique challenges, as therapeutic goals often extend beyond glycemic control to support cancer treatment outcomes.This complimentary on-demand webinar will address the knowledge and practice gaps surrounding the pathophysiology of diabetes in cancer patients and the impact of antineoplastic therapies on diabetes management, helping clinicians refine strategies for this complex patient…
more
Dear AACE Community,
As we enter November, I am encouraged by the progress made throughout October and energized by the opportunities that lie ahead. Below is a recap of last month’s highlights and a preview of this month’s upcoming international programs.
Looking Back: October Highlights
Cleveland Clinic Intensive Review of Endocrinology & Metabolism, Cleveland, Ohio (Oct. 3–5): We were proud to partner with the Cleveland Clinic for their
Intensive Review of Endocrinology and Metabolism program, designed to prepare participants for the…
moreOsteoporosis and osteopenia are chronic conditions that significantly increase the risk of fractures both in the United States and globally. Effective management requires healthcare professionals to understand bone metabolism and the physiological changes that contribute to bone loss. Recognizing these conditions as chronic diseases is essential for identifying risk factors early and initiating timely interventions to prevent fractures and related disabilities. This program is designed to provide participants with current and emerging treatment options to improve patient outcomes in bone…
more
MASLD and MASH Coding Pocket Guide
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction–Associated Steatohepatitis (MASH)
Importance of Correct Coding in Laboratory Orders
Accurate coding in laboratory orders is crucial for the proper diagnosis and treatment of MASH/MASLD. Using incorrect ICD-10-CM diagnosis codes can result in insurance denials for testing coverage, shifting the financial responsibility to patients. With the strict reimbursement guidelines set by both public and private insurers for laboratory tests, it… moreI am pleased to report to you the results of the AACE 2025 Election for open AACE Officer and Board positions for 2026. I would also like to thank the members of the Nominating Committee for their objective and in-depth evaluation of the excellent candidates submitted for consideration. Your Nominating Committee conducted the election process in accordance with Chapter 6 – Election Procedures, of the AACE Bylaws and submitted a single slate of candidates for open Officer and Board positions. On October 11, 2025, the Board of Directors, upon an affirmative 2/3 vote, approved the AACE…
moreSpecialty Society Grant Program
Request for Applications Due December 3, 2025
The Council of Medical Specialty Societies (CMSS), with support from The John A. Hartford Foundation, is providing an opportunity for specialty societies to incorporate evidence-based age-friendly care into specialty ambulatory care for older adults. CMSS will provide grant awards to selected specialty societies to improve the quality of care of older adults through the integration of the evidence-based Age-Friendly Health Systems 4Ms Framework (What Matters, Medication,…
moreDeadline to submit: January 15, 2026 | This initiative is supported by an independent grant from LillyPurpose of Project COMPASS Project COMPASS is a national quality improvement (QI) initiative designed by the American Association of Clinical Endocrinology (AACE) to improve the diagnosis and management of obesity across U.S. health systems. The project aligns with AACE’s Global Education and Quality Improvement Priorities (2024–2028). Endocrine practices selected for participation will engage in data-driven improvement cycles, education, and…
more
